Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
Seeking Alpha
Tuesday, September 18, 2012 - 11:09am
tags:
PDL Biopharma, Novartis, Seattle Genetics, Pfizer, JNJ, Eli Lilly, GSK, Bristol-Myers Squibb
IND Submission by Synergy Pharma
Yahoo/Zacks
Tuesday, September 18, 2012 - 10:40am
tags:
Synergy Pharmaceuticals, SP-333, IBD, inflammatory bowel disease
New Data on Merck's Insomnia Drug
Yahoo/Zacks
Tuesday, September 18, 2012 - 10:37am
tags:
suvorexant, Merck, insomnia, Sanofi, Pfizer
Vical and Bristol-Myers Ink Deal
Yahoo/Zacks
Monday, September 17, 2012 - 3:50pm
tags:
Vical, Bristol-Myers Squibb, Vaxfectin
Humira and the Dawn of AbbVie
Motley Fool
Monday, September 17, 2012 - 3:47pm
tags:
Humira, Abbott Labs, AbbVie
Pfizer study shows tofacitinib monotherapy superior to methotrexate
Yahoo/Fly on the Wall
Monday, September 17, 2012 - 3:46pm
tags:
Pfizer, rheumatoid arthritis, tofacitinib
A Look At Zogenix - Zohydro Drug Information And Analysis
Seeking Alpha
Monday, September 17, 2012 - 3:45pm
tags:
Zogenix, Zohydro, chronic pain
Casualties of an R&D war? Hep C trial patients accuse Bristol-Myers of recklessness
Fierce Biotech
Monday, September 17, 2012 - 12:04pm
tags:
R&D, Bristol-Myers Squibb, hepatitis C, BMS-094
Pfizer, GSK, and NovaDigm Therapeutics test MRSA vaccines
Bloomberg
Monday, September 17, 2012 - 12:01pm
tags:
NovaDigm Therapeutics, Pfizer, MRSA, vaccines, GSK
Chinese co to buy Complete Genomics for $117.6 million
Reuters
Monday, September 17, 2012 - 11:20am
tags:
M&A, China, Complete Genomics, BGI-Shenzhen
Targacept says trial for ADHDi drug did not meet primary outcome measure
Yahoo/Fly on the Wall
Monday, September 17, 2012 - 11:06am
tags:
ADHDi, ADHD, Targacept, TC-5619
3 High Beta Liquid Small-Cap Biotechnology Stocks That Are Breaking Out
Seeking Alpha
Monday, September 17, 2012 - 11:05am
tags:
Cel-Sci, InterMune, Savient
Lilly And Social Media
Pharmalot
Monday, September 17, 2012 - 11:03am
tags:
Eli Lilly, social media
Threshold's Pancreatic Cancer Drug Boosts Survival -- With an Asterisk
TheStreet.com
Monday, September 17, 2012 - 11:01am
tags:
pancreatic cancer, Threshold Pharmaceuticals, TH-302
Heroes And Zeros: Arena Pharmaceuticals And Avanir Pharmaceuticals
Seeking Alpha
Monday, September 17, 2012 - 10:53am
tags:
Arena Pharmaceuticals, Avanir, Eisai
Regeneron Eylea likely to be approved for CRVO, says RBC Capital
Yahoo/Fly on the Wall
Monday, September 17, 2012 - 10:51am
tags:
Regeneron, Eylea, central retinal vein occlusion
Vivus Quietly Notes In 8-k That Qsymia Is Now Commercially Available
Yahoo/Reuters
Monday, September 17, 2012 - 10:13am
tags:
Qsymia, obesity, Vivus, Topiramate, J&J
[video] Can an Outsider Get Johnson & Johnson on Track?
Bloomberg
Monday, September 17, 2012 - 10:12am
tags:
J&J
Will Procter & Gamble Continue to Rise in 2012?
Motley Fool
Monday, September 17, 2012 - 10:10am
tags:
P&G
Anthera announces advancement of blisibimod in Phase 3 development
The Fly on the Wall
Monday, September 17, 2012 - 10:09am
tags:
blisibimod, Anthera, lupus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.